High-risk human papillomavirus in oral squamous cell carcinoma of young patients

International Journal of Cancer

Volumn 130, Issue 8, 2012, Pages 1726-1732

  Kaminagakura, Estela ^a   Villa, Luísa Lina ^b   Andreoli, Maria Antonieta ^b   Sobrinho, João Simão ^b   Vartanian, José Guilherme ^a   Soares, Fernando Augusto ^a   Nishimoto, Inês Nobuko ^a   Rocha, Rafael ^a   Kowalski, Luiz Paulo ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

age; high risk HPVs; HPV16; oral carcinomas; p16

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P16; PROTEIN P16 INK4; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DOT HYBRIDIZATION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS LOAD; VIRUS TYPING; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857481014     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26185     Document Type: Article

References (41)

1. Barnes L, Eveson JW, Reichart P, Sidransky D,; World Health Organization. Classification of tumors. Pathology and genetics head and neck. Lyon: IARC Press, 2005. 430 p.
2. Myers JN, Elkins T, Roberts D, Byers RM,. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000; 122: 44-51.
3. Pitman KT, Johnson JT, Wagner RL, Myers EN,. Cancer of the tongue in patients less than forty. Head Neck 2000; 22: 297-302.
4. Llewellyn CD, Johnson NW, Warnakulasuriya KA,. Risk factors for squamous cell carcinoma of the oral cavity in young peopleâ€"a comprehensive literature review. Oral Oncol 2001; 37: 401-18; Review.
5. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S,. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 2004; 40: 304-13.
6. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, Foukas P, Kyroudi A, Laskaris G, Herrington CS, Kittas C,. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000; 13: 644-53.
7. Kojima A, Maeda H, Sugita Y, Tanaka S, Kameyama Y,. Human papillomavirus type 38 infection in oral squamous cell carcinomas. Oral Oncol 2002; 38: 591-6.
8. Koppikar P, deVilliers EM, Mulherkar R,. Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 2005; 113: 946-50.
9. Lim KP, Hamid S, Lau SH, Teo SH, Cheong SC,. HPV infection and the alterations of the pRB pathway in oral carcinogenesis. Oncol Rep 2007; 17: 1321-6.
10. Pintos J, Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP, Herrero R, Coutlée F, Franco EL,. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol 2008; 44: 242-50.
11. Rittà M, De Andrea M, Mondini M, Mazibrada J, Giordano C, Pecorari G, Garzaro M, Landolfo V, Schena M, Chiusa L, Landolfo S,. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck 2009; 31: 318-27.
12. zur Hausen H,. Papillomavirus infectionsâ€"a major cause of human cancers. Biochim Biophys Acta 1996; 1288: F55-78; Review.
13. Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho OP, Salo T,. Prognostic factors in tongue cancerâ€"relative importance of demographic, clinical and histopathological factors. Br J Cancer 2000; 83: 614-9.
14. El-Mofty SK, Lu DW,. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2003; 27: 1463-70.
15. Dahlgren L, Dahlstrand HM, Lindquist D, Högmo A, BjörnestÃl L, Lindholm J, Lundberg B, Dalianis T, Munck-Wikland E,. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 2004; 112: 1015-9.
16. INK4A, p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 344-52.
17. Liang XH, Lewis J, Foote R, Smith D, Kademani D,. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg 2008; 66: 1875-80.
18. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH,. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104: 336-44.
19. Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP,. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108: 766-72.
20. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A,. Molecular classification identifies a subset of human papillomavirusâ€"associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-47.
21. Sisk EA, Bradford CR, Jacob A, Yian CH, Staton KM, Tang G, Harris MO, Carey TE, Lancaster WD, Gregoire L,. Human papillomavirus infection in "young" versus "old" patients with squamous cell carcinoma of the head and neck. Head Neck 2000; 22: 649-57.
22. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML,. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-9.
23. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM,. AJCC cancer staging handbook. Springer Verlag. 2002. 484 p.
24. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, Liu D, Lim H, Taylor CR,. DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem 2002; 50: 1005-11.
25. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N,. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-4.
26. Manos MM, Ting T, Wright DK, Lewis AJ, Broker TR, Wolinsky SM,. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cell Mol Diagnost Hum Cancer 1989; 7: 209-14.
27. Sanguinetti CJ, Dias Neto E, Simpson AJ,. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994; 17: 915-9.
28. Jacobs MV, de Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM,. Group-specific differentiation between high and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33: 901-5.
29. Kreimer AR, Clifford GM, Boyle P, Franceschi S,. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-75.
30. Chuang AY, Chuang TC, Chang S, Zhou S, Begum S, Westra WH, Ha PK, Koch WM, Califano JA,. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 2008; 44: 915-9.
31. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R,. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-20.
32. Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan'gina O, Schwartz SM, Purdue MP, Pilarska A, Eluf-Neto J, Menezes A, McClean MD, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010; 39: 166-81.
33. Smith EM, Ritchie JM, Yankowitz J, Wang D, Turek LP, Haugen TH,. HPV prevalence and concordance in the cervix and oral cavity of pregnant women. Infect Dis Obstet Gynecol 2004; 12: 45-56.
34. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML,. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-56.
35. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML,. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263-9.
36. Thompson IO, van der Bijl P, van Wyk CW, van Eyk AD,. A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Arch Oral Biol 2001; 46: 1091-8.
37. INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009; 27: 1992-8.
38. (INK4a) protein expression in oral ST lesions a reliable precancerous marker? Int J Oral Maxillofac Surg 2008; 37: 840-6.
39. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH,. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004; 96: 998-1006.
40. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J,. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol 2010; 94: 30-5.
41. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM,. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92: 805-13.